Draft FDA Guidance On Demonstrating Interchangeable Biosimilar Proteins

Published date31 March 2017
AuthorKing L. Wong, Ph.D.
Subject MatterHealth Care,Intellectual Property
Law FirmBioLoquitur

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT